Employees are the FIRST Line of Food Defense (English)
11:36
YouTubeU.S. Food and Drug Administration
Employees are the FIRST Line of Food Defense (English)
Employees FIRST is an FDA initiative that food industry managers can include in their ongoing employee food defense training programs. Employees FIRST educate front ...
307.5K viewsJun 14, 2011
What is Aducanumab
23K views · 65 reactions | Leading Canadian researchers say Alzheimer’s drug aducanumab should not be approved in Canada, at least not yet — despite being approved by the U.S. FDA. Reporting by Christine Birak | CBC News: The National | Facebook
6:02
23K views · 65 reactions | Leading Canadian researchers say Alzheimer’s drug aducanumab should not be approved in Canada, at least not yet — despite being approved by the U.S. FDA. Reporting by Christine Birak | CBC News: The National | Facebook
FacebookCBC News: The National
23.2K viewsAug 13, 2021
In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 years
In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 years
ABC13 HoustonJacqueline Howard,CNN
Jun 7, 2021
In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 years
1:52
In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 years
ABC7 New YorkJacqueline Howard,CNN
Jun 7, 2021
Top videos
What Does FDA Do?
1:06
What Does FDA Do?
YouTubeU.S. Food and Drug
150K viewsOct 3, 2022
What Does FDA Regulate?
1:21
What Does FDA Regulate?
YouTubeU.S. Food and Drug
54.3K viewsJun 24, 2021
Importing FDA-Regulated Products: The Import Process
10:55
Importing FDA-Regulated Products: The Import Process
YouTubeU.S. Food and Drug
64.3K viewsMar 9, 2022
Aducanumab Alzheimers Treatment
A new Alzheimer's drug brings hope, controversy
8:39
A new Alzheimer's drug brings hope, controversy
YouTubeCBS Sunday Morning
75.5K viewsNov 28, 2021
The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ
6:10
The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ
YouTubeThe Wall Street Journal
120.9K viewsMar 29, 2022
Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab
5:54
Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab
YouTubeNutritionFacts.org
21.1K viewsOct 23, 2023